Archives of Medical Research
Volume 37, Issue 6 , Pages 730-735, August 2006

ΔmtDNA4977 Is More Common in Non-tumoral Cells from Gastric Cancer Sample

  • Behnam Kamalidehghan

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Putra, Malaysia
  • ,
  • Massoud Houshmand

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    • Corresponding Author InformationAddress reprint requests to: Massoud Houshmand, Head, Molecular Genetic Diagnostic Department, Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Pajoohesh Blvd. Tehran-Karaj Highway, 17th Km, P.O. Box:14155-6343, Tehran, Iran
  • ,
  • Patimah Ismail

      Affiliations

    • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Putra, Malaysia
  • ,
  • Mehdi Shafa Shariat Panahi

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
  • ,
  • Mohammad Hassan Hosseini Akbari

      Affiliations

    • Department of Pathology, Baghyatolah Hospital, Tehran, Iran

Received 20 October 2005; accepted 3 February 2006.

(ARCMED-D-05-00432)

Background

The aim of this study was to determine the frequency of ΔmtDNA4977 in tumoral cells as compared with adjacent normal cells in gastric cancer.

Methods

In order to investigate whether a high incidence of mutation exists in mitochondrial DNA of gastric cancer tissues, we screened one of common region of the mitochondrial genome by PCR amplification and Southern blot followed by DNA sequence analysis. DNA isolated from these cells was used to amplify hypervariable regions ATPase8/6, COXIII, ND3, ND4 and ND5 of ΔmtDNA4977.

Results

In 107 cancer patients, ΔmtDNA4977 was detected in 6 cases (5.60%) of the tumoral tissues and 18 cases (16.82%) of the non-tumoral tissues that were adjacent to the tumors. Levels of ΔmtDNA4977 deletions were found to be more in non-tumoral tissues than in adjacent tumoral tissues. There was no correlation of patients with certain clinical parameters like age, sex, tumor location and tumor size; however, there was an obvious relationship with intestinal-type of gastric cancer.

Conclusions

Unknown genetic aspects, ambiguous environmental factors and reactive oxygen species (ROS) can cause the ΔmtDNA4977 mutation rate to be increased in gastric cancer. The results suggest that percentage level of ΔmtDNA4977 is less common and intolerable in tumoral tissue, probably because of high metabolism and ROS generation. We supposed that the cells initially had ΔmtDNA4977 transform to tumoral cells and the existed deletion conferred metabolic disadvantage; thus, cells containing such a mtDNA deletion would be overgrown by other cancer cells without this mtDNA deletion. As a result, the presence of ΔmtDNA4977 will be low in tumoral cells.

Key Words: ΔmtDNA4977, Gastric cancer, Tumoral cell

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0188-4409(06)00093-2

doi:10.1016/j.arcmed.2006.02.005

Archives of Medical Research
Volume 37, Issue 6 , Pages 730-735, August 2006